Advertisement

ONN® - OncLive News Network®


Recent Advances in the Management of Non-Melanoma Skin Cancers

October 19th 2022

Dr Nikhil Khushalani reviews recent data updates for the treatment of non-melanoma skin cancers focusing on cutaneous squamous cell carcinoma and basal cell carcinoma.

Post-Conference Perspectives: Urothelial Carcinoma 2022 Year in Review

October 5th 2022

Drs Jeanny B. Aragon-Ching and Srikala Sridhar review key updates in the management of urothelial carcinoma from data presented in 2022.

Metastatic HR+ Breast Cancer: Year in Review

October 4th 2022

Expert oncologists share their perspectives on key updates in the management of hormone receptor–positive metastatic breast cancer from the past year.

OncLive News Network: On Location at ESMO 2022

September 12th 2022

Join us LIVE at this year's 2022 ESMO Congress! OncLive® will broadcast a series of interviews with top thought leaders in breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, and gynecologic malignancies. The experts will share their insights and reactions to the pivotal data presented during the conference.

Post-Conference Perspectives: Breast Cancer Recurrence Monitoring by ctDNA

August 31st 2022

Aditya Bardia, MD, MPH discusses the present and prospective clinical applications of ctDNA monitoring informed by promising data presented at the ASCO 2022 Annual Meeting.

Post-Conference Perspectives: MOUNTAINEER Trials in GI Malignancies

August 3rd 2022

New Frontiers in Breast Cancer: Updates and Advances in Treatment

July 27th 2022

Expert oncologists incorporate personal experience with data from the recent ASCO 2022 annual meeting to highlight optimal testing and management strategies in breast cancer.

Post-Conference Perspectives: Uveal Melanoma

July 22nd 2022

Omid Hamid, MD, and Ryan Sullivan, MD, discuss new updates in uveal melanoma, and an exciting, recently approved agent for treatment of metastatic disease.

The Current and Future State of Immune Checkpoint Inhibitors in NSCLC

July 13th 2022

Expert oncologists reflect on recent clinical trial data to elucidate the evolving treatment landscape of checkpoint inhibition in non–small cell lung cancer.

On the Horizon in NSCLC: Antibody Drug Conjugates

July 13th 2022

Experts discuss current and investigational antibody drug conjugates (ADCs) in non-small cell lung cancer treatment and how they affect therapy approaches.

Post-Conference Perspectives: ctDNA for MRD in Lung Cancer

July 7th 2022

Mark G. Kris, MD, FASCO provides insight on monitoring patients with NSCLC and discusses the developing role of ctDNA.

The Evolving Paradigm in the Treatment of HER2 Positive Metastatic Breast Cancer

July 1st 2022

Vijayakrishna Gadi, MD, PhD, provides an overview of recent advancements in the treatment of HER2+ metastatic breast cancer with special consideration for challenges in the management of patients with CNS metastases.

Updates in the Treatment of Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

June 28th 2022

Jae Park, MD, reviews the current treatment landscape and emerging options for treating adults with relapsed/refractory B-cell acute lymphoblastic leukemia

OncLive News Network: On Location at ASCO 2022

June 5th 2022

Join us LIVE at this year's 2022 ASCO Annual Meeting! OncLive® will broadcast a series of interviews with top thought leaders in breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, and gynecologic malignancies. The experts will share their insights and reactions to the pivotal data presented during the conference.

New Frontiers in Breast Cancer: Updates and Advances in Treatment

May 11th 2022

Experts Joyce A. O’Shaughnessy, MD, and Sara A. Hurvitz, MD, provide comprehensive updates on the optimal workup and management of patients with breast cancer.

Updates in Metastatic HER2 Positive Breast Cancer Treatment

April 21st 2022

Expert perspectives on novel management of HER2+ metastatic breast cancer in the context of recent clinical trials and FDA approvals.

OncLive News Network On Location: ASCO GU 2022

February 17th 2022

Join us LIVE at this year's 2022 Genitourinary Cancers Symposium! OncLive® will broadcast a series of interviews with top thought leaders across cancers of the bladder, prostate, and kidney. The experts will share their insights and reactions to the pivotal data presented during the conference.


ctDNA in Pancreatic and Colorectal Cancer

February 15th 2022

How ctDNA testing is being investigated and used in pancreatic and colorectal cancer in the era of precision medicine.

Updates in CLL: Strategies for Managing Toxicities and Special Patient Considerations

February 11th 2022

Two experts lead a discussion about chronic lymphocytic leukemia (CLL), focusing on updates in management and special considerations when treating with BTK inhibitors.

Updates in SCLC: Advances in Treatment

January 31st 2022

Drs Carl M. Gay and Jared Weiss highlight novel treatment advances for newly diagnosed and relapsed/refractory small cell lung cancer.

Advertisement
Advertisement